MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
As the field of brain health embraces AI and improved usability of EEG hardware, Epitel, Ceribell, Cogitat, and Zeto are pushing the neurological metric into new healthcare settings and use cases.
In this month’s news, start-up device announcements, a first in FDA clearance, and strategic deals from Zimmer Biomet, Globus Medical and more.
Early indicators are positive for the medtech start-up community, with an uptick in funding deals and exits in the first weeks of the new year. Companies focused on heart failure (FIRE1, Alleviant Medical), neurology (Ceribell, Zeto, Saluda Medical), diabetes (Beta Bionics, CeQur), and AI solutions (Neko Health, Quibim) all gained ground recently. But longer-term uncertainties still loom, and the road ahead could be bumpy.